Lecture 19: Innate Immunity Flashcards
5 cardinal signs of Inflammation
- Heat
- Redness
- Swelling
- Pain
- Loss of Function
Fever
- from strong proinflammatory response
- not DIRECTLY caused by pathogenic factors
- cytokines TNF, IL-1, IL-6 are potent inducers
- most pathogens replicate poorly in elevated temps
What are PAMPs?
- Pathogen-associated Molecular Patterns
- unique to particular classes of pathogens
- usually required for survival, cannot be hidden from surface
- not similar to self-Ags
Gram- PAMPs
Porin, Lipopolysaccharide, Lipoprotein
Gram+ PAMPs
Teichoic acid, lipoteichoic acid, peptidoglycan, lipoprotein
Mycobacteria PAMPs
lipoarabinomannan, porin, lipoprotein
Fungi PAMPs
manno-proteins, B-glucan, lipoprotein
Extracellular TLRs and what they recognize
TLR 1/2 - bacterial lipopeptides
TLR 2 - bacterial peptidoglycans
TLR 4 - LPS
TLR 5 - bacterial flagellin
TLR 2/6 - bacterial lipopeptides
Intracellular (endosome) TLRs and what they recognize
TLR 3 - dsRNA
TLR 7 - ssRNA
TLR 8 - ssRNA
TLR 9 - CpG DNA
MyD88, TRIF, IRF, NK-kB
MyD88 - activated by all TLRs, cause NK-kB/IRF act.
TRIF - activated by TLR3/4, cause NK-kB/IRF act.
IRF/NK-kB - transcriptional factors
TLR Deficiencies (MyD88 and IRAK-4 deficiency)
- defective TLRs = innate immune cell cannot kill microbe
- signaling defects = failure to produce cytokines
MyD88/IRAK-4 def: susceptibility to infection either by bacteria or viruses
Inflammasomes and NOD-like Receptors
NLR - scaffolding for signaling platform that activates NF-kB and MAPK pathway
Inflammasome - activates protease caspase 1
- process inactive cytokine precursors into active form (IL-1B and IL-18)
What two cytokines drive inflammation?
IL-1B and IL-18
NLRP3 Inflammasome and Gout
- IL-1B is key cytokine in gout; promotes neutrophil influx into synovium and joint fluid
- pathological hallmark of acute inflammatory attack
- Anti-IL-1 therapy used to treat gout patients
Necrosis and DAMPs
Necrosis: dirty cell death; swelling and rupture of cell membrane, causing inflammation
- strong DAMP release (endogenous danger molecules released from damaged/dying cells during NON-INFECTIOUS INFLAMMATION
- DAMPs recognized by PPRs (pattern recognition receptors)